The Annals Visit the PharmaCE website!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 7 November 2006, www.theannals.com, DOI 10.1345/aph.1H177.
The Annals of Pharmacotherapy: Vol. 40, No. 12, pp. 2277-2278. DOI 10.1345/aph.1H177
© 2006 Harvey Whitney Books Company.
This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geers, H. C.
Right arrow Articles by Heerdink, E. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geers, H. C.
Right arrow Articles by Heerdink, E. R

Early Identification of Long-Term Poor Adherence in Ambulatory Patients

Harm CJ Geers, PharmD

PhD Candidate Division of Pharmacoepidemiology and Pharmacotherapy Faculty of Science Utrecht Institute for Pharmaceutical Sciences Utrecht University Utrecht, Netherlands

Cornelis J de Blaey, PhD

Professor of Pharmaceutical Care Division of Pharmacoepidemiology and Pharmacotherapy Faculty of Science Utrecht Institute for Pharmaceutical Sciences

Antoine CG Egberts, PhD

Professor of Clinical Pharmacoepidemiology Division of Pharmacoepidemiology and Pharmacotherapy Faculty of Science Utrecht Institute for Pharmaceutical Sciences

Marcel L Bouvy, PhD PharmD

Assistant Professor of Pharmaceutical Care Division of Pharmacoepidemiology and Pharmacotherapy Faculty of Science Utrecht Institute for Pharmaceutical Sciences

Eibert R Heerdink, PhD

Assistant Professor of Pharmacotherapy Division of Pharmacoepidemiology and Pharmacotherapy Faculty of Science Utrecht Institute for Pharmaceutical Sciences Utrecht University Sorbonnelaan 16 PO Box 80082 3508 TB Utrecht, Netherlands fax 313/025-39166 e.r.heerdink{at}pharm.uu.nl

Published Online, November 7, 2006. www.theannals.com, DOI 10.1345/aph.1H177


TO THE EDITOR: Poor adherence leads to poor disease control and increased costs.1 Early identification of patients at risk for long-term poor adherence is therefore important. We investigated whether early identification of patients at risk for long-term poor adherence is possible in a community pharmacy setting by performing a case-control study that consisted of a group of patients receiving drug therapy for at least one year.

Methods. The medication possession ratio (MPR), calculated by dividing cumulative days of drug supply by total number of days in the interval in which the drug was obtained, was used as a proxy for nonadherence.2 Cases were patients with an MPR of 80% or less in the year following the sixth dispensing of a drug; controls were all other patients within the study population. We recalculated MPR one year after the sixth dispensing to ensure independence of the data for the first 5 refills from the one year adherence data. The main determinant was MPR at fills 2 (average 43 days), 3 (103), 4 (161), and 5 (222). Other predictors were patient age, number of prescriptions in one year, and total number of drugs used between fills 1 and 5. We did not include number of daily doses as a possible predictor due to changes in dosing frequencies over time. A multivariate logistic regression model was used to assign a risk score, with the regression coefficient multiplied by 10 and rounded to the nearest integer as the score for each predictor variable. Total risk scores (sum of all individual predictors) were calculated for each patient.

Results. From 3845 patients who received new prescriptions during the study period, we identified 606 (16%) cases and 3239 controls. Average age of patients was 67.1 years, and 41.7% were male. Average number of different medications being taken was 11.7 per patient between fills 1 and 6. Overall nonadherence in our study was low (16%) compared with the percentage in other studies (as high as 50%1), probably because we included only patients who were persistent for over one year, thus excluding initial nonadherence that is frequently present in patients who discontinue drug therapy prematurely.3

Table 1 shows adjusted regression coefficients and individual risk scores for each predictor included at the third fill. Poor MPR at that time (MPR-3) and a drug regimen of no more than 30 prescriptions per person were the strongest predictors of nonadherence. The type of drug had no effect on adherence. The maximum total risk score was 28. Sensitivity at a total risk score greater than or equal to 17 was 35% and specificity was 87%.


View this table:
[in this window]
[in a new window]

 
Table 1. Regression Coefficient and Score of Each Predictor Included at the Third Fill

 

Old age and a drug regimen consisting of fewer medications have previously been associated with poor drug adherence.4,5

If we choose a cut-off total risk value of at least 17, our model improves efficiency in identifying nonadherence from 16% to 35%. This means that an adherence improvement strategy directed at the total population of this study could theoretically be useful for 16% of patients, while the same strategy could be applicable to 35% of patients when using our model. The number needed to screen is therefore 5.2 (1/[0.35-0.16]), meaning that we would have to screen 5.2 cases with our model to identify one who was poorly adherent.

Our model has limitations. For example, we do not know the proportion of delayed refills due to a patient's hospitalization or inability to visit the pharmacy. Further development and validation in other healthcare systems are needed.

References

  1. World Health Organization. Adherence to long-term therapies: evidence for action. WHO;2003:7 -11. www.who.int/chronic_conditions/adherencereport/en (accessed 2006 Nov 1).
  2. Steiner JF, Prochazka AV. The assessment of refill compliance using pharmacy records: methods, validity, and applications. J Clin Epidemiol 1997;50:105-16.[CrossRef][Medline]
  3. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. Initial non-compliance with antihypertensive monotherapy is followed by complete discontinuation of antihypertensive therapy. Pharmacoepidemiol Drug Saf 2006;15:587-93.[CrossRef][Medline]
  4. Schectman JM, Bovbjerg VE, Voss JD. Predictors of medication-refill adherence in an indigent rural population. Med Care 2001;40:1294-300.[CrossRef]
  5. Shalansky SJ, Levy AR. Effect of number of medications on cardiovascular therapy adherence. Ann Pharmacother 2002;36: 1532-9. DOI 10.1345/aph.1C044.[Abstract]




This Article
Right arrow PDF
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Geers, H. C.
Right arrow Articles by Heerdink, E. R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Geers, H. C.
Right arrow Articles by Heerdink, E. R


homecopy help contact us subscription past issues search current issue